I won't diluteshareholdersOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAKis our leadassetWe will openupinternationalsites forMino-Lok trialI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Myron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BI/ONTAK'spotentialmarket is>$300mMino-WrapWe haveenough cashto go wellinto 2023The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Insidersinvested$26.5mAn actualiMSCupdateWe had aphase 2btrial with100%efficacyWe intendto submita BLA in2H 2022There are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityOnly biotechwith 2 Myron'son theleadershipteamNot manycompaniesthis size with2 late stageassetsWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfI/ONTAKwas thebest deal Iever madeHemorrhoidsis a $2BmarketMino-Lokis our leadassetI won't diluteshareholdersOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAKis our leadassetWe will openupinternationalsites forMino-Lok trialI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Myron Holubiakand I founded aprivatecompany in2013Mino-Lokpotentialmarket>$1BI/ONTAK'spotentialmarket is>$300mMino-WrapWe haveenough cashto go wellinto 2023The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Insidersinvested$26.5mAn actualiMSCupdateWe had aphase 2btrial with100%efficacyWe intendto submita BLA in2H 2022There are noFDAapproveddrugs to treathemorrhoidsWe willhaveexclusivityOnly biotechwith 2 Myron'son theleadershipteamNot manycompaniesthis size with2 late stageassetsWe expect tofinish theMino-Loktrial this yearI'm ashareholdermyselfI/ONTAKwas thebest deal Iever madeHemorrhoidsis a $2BmarketMino-Lokis our leadasset

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I won't dilute shareholders
  2. Our Halo-Lido trial will have final patient by end of 2022
  3. I/ONTAK is our lead asset
  4. We will open up international sites for Mino-Lok trial
  5. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  6. Myron Holubiak and I founded a private company in 2013
  7. Mino-Lok potential market >$1B
  8. I/ONTAK's potential market is >$300m
  9. Mino-Wrap
  10. We have enough cash to go well into 2023
  11. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  12. Insiders invested $26.5m
  13. An actual iMSC update
  14. We had a phase 2b trial with 100% efficacy
  15. We intend to submit a BLA in 2H 2022
  16. There are no FDA approved drugs to treat hemorrhoids
  17. We will have exclusivity
  18. Only biotech with 2 Myron's on the leadership team
  19. Not many companies this size with 2 late stage assets
  20. We expect to finish the Mino-Lok trial this year
  21. I'm a shareholder myself
  22. I/ONTAK was the best deal I ever made
  23. Hemorrhoids is a $2B market
  24. Mino-Lok is our lead asset